Majority Of Claims In EpiPen Stock-Drop Suit Allowed To Proceed, Judge Rules
NEW YORK — A federal judge in New York on April 6 ruled that lead plaintiffs in a securities class action against drugmaker Mylan N.V. and certain of its current and...To view the full article, register now.
Already a subscriber? Click here to view full article